Article Details
Retrieved on: 2021-04-22 11:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Valneva announced yesterday that a phase 3 trial will compare its COVID-19 vaccine candidate to AstraZeneca's jab, which is conditionally approved ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here